IceCure Medical (ICCM) EPS (Basic) (2020 - 2026)

IceCure Medical (ICCM) has 7 years of EPS (Basic) data on file, last reported at $1.73 in Q1 2026.

• On a quarterly basis, EPS (Basic) fell 7.27% year-over-year to $1.73 in Q1 2026; TTM through Mar 2026 was $6.41, a 244.32% increase from a year earlier, with the FY2025 full-year figure at -$5.61, up 59.86% from the prior year.
• EPS (Basic) for Q1 2026 stood at $1.73, down from $2.0 in the prior quarter.
• Over the last five years, EPS (Basic) for ICCM reached as high as $3.61 in Q1 2022 and fell as low as -$37.97 in Q4 2022.
• Historically, EPS (Basic) has averaged -$2.7 across 5 years, with a median of $2.0 in 2025.
• Across the five-year window, EPS (Basic) decreased 28.02% in 2024 and surged 117.55% in 2025, its largest moves.
• Year by year, EPS (Basic) stood at -$37.97 in 2022, then increased by 18.8% to -$30.84 in 2023, then soared by 63.0% to -$11.41 in 2024, then surged by 117.55% to $2.0 in 2025, then slipped by 13.5% to $1.73 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $1.73 in Q1 2026, $2.0 in Q4 2025, and $1.91 in Q3 2025.